Meeting
2015 Gastrointestinal Cancers Symposium
Stereotactic body radiotherapy (SBRT) reirradiation for recurrent pancreas cancer.
Authors
Rabia N Dagoglu
Beth Israel Deaconess Medical Center, Boston, MA
Rabia N Dagoglu , Mark Callery , James Moser , Jennifer F. Tseng , Tara Kent , Andrea J. Bullock , Rebecca A. Miksad , Joseph Douglas Mancias , Anand Mahadevan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 451)
DOI
10.1200/jco.2015.33.3_suppl.451
Abstract #
451
Poster Bd #
E18
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Stereotactic reirradiation for local prostate cancer recurrence: Mono-institutional experience of 108 patients.
First Author: Manon Baty
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Liver toxicity following reirradiation and multiple-target SBRT for primary hepatocellular carcinoma.
First Author: Jacob Hall
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Targeted intra-arterial gemcitabine vs. continuation of IV gemcitabine plus nab-paclitaxel following induction with sequential IV gemcitabine plus nab-paclitaxel and radiotherapy for unresectable locally advanced pancreatic cancer (TIGeR-PaC): A randomized phase 3 multicenter study.
First Author: Michael J. Pishvaian
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A phase I clinical trial of stereotactic body radiotherapy with atezolizumab and bevacizumab in advanced hepatocellular carcinoma.
First Author: Timothy J Brown